挥发性有机化合物在检测溃疡性结肠炎活动性疾病中的潜力
本研究纳入72例溃疡性结肠炎(UC)患者(132份呼气样本,其中活动期62份、缓解期70份)和22例非UC结肠炎患者,采用气相色谱-飞行时间质谱分析呼气挥发性有机化合物(VOCs)。11种VOCs在独立内部验证集中预测活动期与缓解期UC的灵敏度为92%、特异度为77%(AUC 0.94),主成分分析可清晰区分非UC结肠炎与UC患者。
要点
- 11种VOCs在独立内部验证集中预测活动期与缓解期UC,灵敏度92%、特异度77%(AUC 0.94)。
- 主成分分析可清晰区分非UC结肠炎患者与活动期及缓解期UC患者。
- VOCs展现出作为监测UC炎症的新型非侵入性生物标志物的潜力。
核心结论
- 挥发性有机化合物能准确区分UC活动期与缓解期,且UC的VOCs谱与非UC结肠炎患者明显不同。
- VOCs展现出作为监测UC炎症的新型非侵入性生物标志物的潜力。
研究设计与样本
- UC患者参与为期1年的研究,每次门诊随访收集临床活动指数、血液、粪便和呼气样本。
- 横断面分析纳入粪钙卫蛋白>250 μg/g的明确活动期患者,以及简单临床结肠炎活动指数<3、C反应蛋白<5 mg/L且粪钙卫蛋白<100 μg/g的非活动期患者。
- 非UC结肠炎通过粪便培养或影像学评估确认。
- 呼气样本采用气相色谱-飞行时间质谱和基于核的方法分析以识别有鉴别力的VOCs。
- 共纳入72例UC患者(132份呼气样本,活动期62份、缓解期70份)和22例非UC结肠炎患者(22份样本)。
主要发现
- 11种VOCs在独立内部验证集中预测活动期与缓解期UC,灵敏度92%、特异度77%(AUC 0.94)。
- 主成分分析可清晰区分非UC结肠炎患者与活动期及缓解期UC患者。
关键数值与推荐
- 活动期定义:粪钙卫蛋白>250 μg/g。
- 非活动期定义:简单临床结肠炎活动指数<3、C反应蛋白<5 mg/L且粪钙卫蛋白<100 μg/g。
- 11种VOCs预测活动期与缓解期UC:灵敏度92%、特异度77%、AUC 0.94(独立内部验证集)。
临床怎么用
- 原文未据此给出临床推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: To optimise treatment of ulcerative colitis (UC), patients need repeated assessment of mucosal inflammation. Current non-invasive biomarkers and clinical activity indices do not accurately reflect disease activity in all patients and cannot discriminate UC from non-UC colitis. Volatile organic compounds (VOCs) in exhaled air could be predictive of active disease or remission in Crohn's disease. AIM: To investigate whether VOCs are able to differentiate between active UC, UC in remission and non-UC colitis. METHODS: UC patients participated in a 1-year study. Clinical activity index, blood, faecal and breath samples were collected at each out-patient visit. Patients with clear defined active faecal calprotectin >250 μg/g and inactive disease (Simple Clinical Colitis Activity Index <3, C-reactive protein <5 mg/L and faecal calprotectin <100 μg/g) were included for cross-sectional analysis. Non-UC colitis was confirmed by stool culture or radiological evaluation. Breath samples were analysed by gas chromatography time-of-flight mass spectrometry and kernel-based method to identify discriminating VOCs. RESULTS: In total, 72 UC (132 breath samples; 62 active; 70 remission) and 22 non-UC-colitis patients (22 samples) were included. Eleven VOCs predicted active vs. inactive UC in an independent internal validation set with 92% sensitivity and 77% specificity (AUC 0.94). Non-UC colitis patients could be clearly separated from active and inactive UC patients with principal component analysis. CONCLUSIONS: Volatile organic compounds can accurately distinguish active disease from remission in UC and profiles in UC are clearly different from profiles in non-UC colitis patients. VOCs have demonstrated potential as new non-invasive biomarker to monitor inflammation in UC.
引用
- Smolinska A, Bodelier AG, Dallinga JW, et al. The potential of volatile organic compounds for the detection of active disease in patients with ulcerative colitis. Aliment Pharmacol Ther. 2017. PMID: 28239876. doi:10.1111/apt.14004
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。